Therefore, this leads us to explore the carcinogenic effects of GPR34 on ATC and its specific regulatory mechanisms, and further elucidate the impact of GPR34 on cell fate, which may provide a new effective target for cancer therapy. This evidence concerns the gene GPR34 and cancer.